Anterior uveitis and concurrent allergic conjunctivitis associated with long-term use of topical 0.2% brimonidine tartrate.
Becker
Heidi I
HI
Department of Surgery (Ophthalmology), Dartmouth Medical School, Hannover, NH 03755-3842, USA.
Walton
R Christopher
RC
Diamant
Jonathan I
JI
Zegans
Michael E
ME
D000287:Administration, Topical; D000368:Aged; D000369:Aged, 80 and over; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000068438:Brimonidine Tartrate; D003233:Conjunctivitis, Allergic / Q000139:chemically induced* / Q000188:drug therapy; D005260:Female; D005901:Glaucoma / Q000188:drug therapy; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D008297:Male; D009883:Ophthalmic Solutions; D011239:Prednisolone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011810:Quinoxalines / Q000008:administration & dosage / Q000009:adverse effects*; D014606:Uveitis, Anterior / Q000139:chemically induced* / Q000188:drug therapy
D000959:Antihypertensive Agents; D005938:Glucocorticoids; D009883:Ophthalmic Solutions; D011810:Quinoxalines; D000068438:Brimonidine Tartrate; C009935:prednisolone acetate; D011239:Prednisolone